Genome of recombinant herpes virus, herpes virus, pharmaceutical composition, use of herpes virus or pharmaceutical composition, and methods for expressing, intensifying, increasing, amplifying and / or supplementing the levels of a polypeptide in one or more cells of an eye, to provide prophylactic, palliative or therapeutic relief of one or more signs or symptoms of an eye condition or disease and to treat an eye condition or disease.

BR112025022098A2Pending Publication Date: 2026-09-08
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
BR112025022098
Authority / Receiving Office
BR · BR
Patent Type
Applications
Publication Date
2026-09-08

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.